CTOs on the Move

CardioDX

www.cardiodx.com

 
The mission of Crescendo Bioscience, Inc. is to enable more effective management of autoimmune and inflammatory diseases by providing quantitative, objective molecular tests and disease information services to rheumatologists and patients. Crescendo Bioscience is currently focused on rheumatoid arthritis (RA), a debilitating, chronic disease affecting over 1.5 million people in the United States and more than 2 million in Europe. Although there is no known cure for RA, multiple therapies are available, with widely differing levels of effectiveness and significant potential toxicities. Choosing the optimal treatment from among these therapeutic alternatives is a tremendous challenge. At Crescendo Bioscience, we are ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cardiodx.com
  • 600 Saginaw Drive
    Redwood City, CA USA 94063
  • Phone: 650.475.2788

Executives

Name Title Contact Details

Similar Companies

AlohaCare

AlohaCare is a Honolulu, HI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Specialty Laboratories

Specialty Laboratories, Inc. (Specialty Laboratories) is a hospital-focused clinical reference laboratory, performing testing services for hospitals, laboratories and physician specialists in the United States. The Company offers a menu of esoteric

Natera

Natera Inc. is a genetic testing company that specializes in analyzing tiny quantities of DNA for reproductive health. Natera operates a CLIA-certified laboratory in San Carlos, Calif., providing a host of preconception and prenatal genetic testing services. Test offerings include pre-implantation genetic diagnosis to identify chromosomal anomalies or inherited genetic conditions in embryos generated during an IVF cycle; products-of-conception testing following miscarriage to analyze fetal chromosomes and understand the cause of the pregnancy loss; non-invasive prenatal testing to determine paternity; carrier screening to detect whether parents carry genetic variations that may result in disease in the child; and Panorama, a safe, simple test for pregnant women that identifies the most common chromosomal anomalies in a fetus as early as nine weeks of gestation. Natera's PreNATUS clinical trial for non-invasive screening of fetal chromosomal anomalies is funded by the NIH and is being conducted by the leaders in maternal-fetal medicine in the United States. These tests were developed by Natera, a laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA). They have not been cleared or approved by the U.S. Food and Drug Administration (FDA). In August, Natera was selected by the World Economic Forum as a Technology Pioneer for innovations in prenatal care. For more information, visit www.natera.com.

CASLPO

CASLPO is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardinal Laboratories

Cardinal Laboratories is a Crescent Springs, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.